Christian Rothe
Analyst · Morgan Stanley. Please go ahead. Your line is open
Yeah, sure, Chris. When you think about this kind of where we went from Q1 into Q2, really, really nice margin expansion. I think earlier in the year, we would have gotten some grief from folks about the ramp on the margin expansion through the course of the year. We did do a really good job through Q2 execution to derisk a lot of that. And again, we're taking our segment operating margin guide number up from 19% where it was previously to 20% now. And so we still have opportunities to expand those margins. But again, we did -- a lot of that heavy lift was done in the second quarter, and we want to continue to build off of that. But as I said in my prepared comments, we're talking about basis points, not full percentage points. I think your math around kind of what the second half implied number is. Yeah, you're in that ballpark. The ability of this team to continue to execute, I have a lot of confidence in, the key is that we're talking about some really nice numbers year-over-year where we're still getting benefits. Sequentially, when we're talking about the cost reduction and margin expansion activities, those are the millions, probably not tens of millions. But again, we're feeling pretty good about that. On your question on whether or not we can get margin expansion in a tariff-based environment, again, we're really -- our objective is, is that we're going to try to give that information to you all around what the impact of tariffs is for each of these quarters going forward. We're super focused on operational execution on the base business, excluding what happens with the tariff side. And on the tariff side, we're focused on the recovery portion of it. That's really -- there are two separate things for us. Base business, continued growth, continued margin expansion, and let's go execute.